Hub : Traits

Time to tail flick, vehicle, after self-admin

Time in sec to remove tail from noxious stimuli under vehicle conditions in the second tail flick after self admin

Tags: Behavior · Heroin

Project: u01_peter_kalivas

5 loci · 5 genes with independent associations · 5 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr4	95890735	97085238	1	1	1.50e-13	4.72e-03	1.00e+00	Serbp1
2	chr7	14449451	15768722	1	1	1.01e-13	3.87e-01	1.00e+00	LOC102551633
3	chr8	108585012	109845634	1	1	2.28e-10	2.07e-01	3.17e-23	Klhdc8b
4	chr9	75969545	77365260	1	1	2.32e-19	9.91e-05	1.00e+00	Zfand2b
5	chr12	42134827	43495469	1	1	4.95e-08	5.01e-03	4.89e-05	Selplg

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
BMI with tail	13.63	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
BMI without tail	28.63	3	2	40	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Body weight	11.44	2	1	20	0	1.00e+00	Klhdc8b Selplg
Epididymis fat weight	111.28	1	1	20	0	1.00e+00	Zfand2b
Heart weight	44.47	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Left kidney weight	27.6	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Right kidney weight	24.38	3	2	40	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Tail length	35.03	4	1	20	0.5	5.01e-01	Klhdc8b Selplg Serbp1 Zfand2b
Length with tail	5.44	4	1	20	0.09	9.14e-01	Klhdc8b Selplg Serbp1 Zfand2b
Length without tail	77.43	1	1	20	0	1.00e+00	Zfand2b
Liver weight, left	10.62	2	0	0	0	1.00e+00	Klhdc8b Serbp1
Liver weight, right	17.57	1	1	20	0	1.00e+00	Zfand2b
Parametrial fat weight	9.99	1	0	0	0	1.00e+00	Zfand2b
Retroperitoneal fat weight	5.64	3	0	0	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Intraocular pressure	22.61	3	1	20	0	1.00e+00	Selplg Serbp1 Zfand2b
Soleus weight	8.84	1	0	0	0	1.00e+00	Klhdc8b
Tibia length	10.96	1	1	20	0	1.00e+00	Klhdc8b
Number of licking bursts	28.51	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Food consumed during 24 hour testing period	12.4	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Times rat made contact with spout	9.25	1	0	0	0	1.00e+00	Zfand2b
Mean time between licks in bursts	6.49	3	0	0	0	1.00e+00	Klhdc8b Selplg Zfand2b
Mean num. licks in bursts	14.92	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Std. dev. time between licks in bursts	12.12	1	0	0	0	1.00e+00	Zfand2b
Water consumed over 24 hours	21.34	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging indifference point 0 sec	9.24	3	0	0	0	1.00e+00	Klhdc8b LOC102551633 Zfand2b
Patch foraging indifference point AUC	18.18	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Indifference point function ln k	45.4	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Indifference point function log k	45.4	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 0 sec	13.2	3	1	20	0	1.00e+00	Klhdc8b LOC102551633 Zfand2b
Patch foraging total patch changes 18 sec	21.51	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Patch foraging total patch changes 24 sec	42.08	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 6 sec	12.61	3	1	20	0	1.00e+00	LOC102551633 Serbp1 Zfand2b
Patch foraging time to switch 0 sec	14.94	3	1	20	0	1.00e+00	Klhdc8b Selplg Zfand2b
Patch foraging water rate 0 sec	17.91	3	1	20	0	1.00e+00	Selplg Serbp1 Zfand2b
Patch foraging water rate 12 sec	69.49	1	1	20	0	1.00e+00	Zfand2b
Patch foraging water rate 18 sec	7.63	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Patch foraging water rate 24 sec	12.61	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 6 sec	35.43	1	1	20	0	1.00e+00	Zfand2b
Locomotor activity	24.78	3	1	20	0	1.00e+00	Klhdc8b LOC102551633 Zfand2b
Locomotor testing distance	55.86	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing rearing	99.51	1	1	20	0	1.00e+00	Zfand2b
Light reinforcement 1	13.88	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Light reinforcement 2	6.91	3	0	0	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Reaction time number correct	66.72	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean minus median	179.03	1	1	20	0	1.00e+00	Zfand2b
Reaction time mean minus median AUC	232.47	1	1	20	0	1.00e+00	Zfand2b
Reaction time num false alarms	5.73	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Reaction time num false alarms AUC	17.01	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials correct on left	66.72	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials on left	63.1	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean	36.11	1	1	20	0	1.00e+00	Zfand2b
Reaction time mean AUC	21.6	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Median of all reaction times	14.09	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Reaction time omissions	35.15	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time false alarm rate	20.24	1	1	20	0	1.00e+00	Klhdc8b
Reaction time premature initiations	17.81	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Std. dev. reaction times	72.92	1	1	20	0	1.00e+00	Zfand2b
Reaction time trials completed	63.1	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials AUC	64.7	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Social response proportion	16.43	1	0	0	0	1.00e+00	Selplg
Social time	5.29	1	0	0	0	1.00e+00	Selplg
Conditioned locomotion	28.4	1	1	20	0	1.00e+00	Klhdc8b
Cocaine response after cond. corrected	12.71	1	0	0	0	1.00e+00	Zfand2b
Cocaine response after cond. not corrected	13.66	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Cocaine response before conditioning	38.66	1	1	20	0	1.00e+00	Klhdc8b
Saline control response	8.43	1	0	0	0	1.00e+00	Zfand2b
Condit. Reinf. lever presses	5.55	1	0	0	0	1.00e+00	Zfand2b
Pavlov. Cond. magazine entry number	30	1	1	20	0	1.00e+00	Klhdc8b
Pavlov. Cond. intertrial magazine entries	7.56	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. response bias	5.18	1	0	0	0	1.00e+00	Klhdc8b
Conditioned reinforcement - actives	152.54	1	1	20	0	1.00e+00	Zfand2b
Conditioned reinforcement - inactives	76.2	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	25.36	3	1	20	0	1.00e+00	LOC102551633 Serbp1 Zfand2b
Intermittent access intake day 1-15 change	156.77	1	1	20	0	1.00e+00	Zfand2b
Intermittent access intake escalation	117.41	1	1	20	0	1.00e+00	Zfand2b
Intermittent access intake escalation 2	13.41	1	0	0	0	1.00e+00	LOC102551633
Intermitt. access day 1 inactive lever presses	91.66	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Intermitt. access day 15 inactive lever presses	162.52	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Intermitt. access escalation Index	57.91	1	1	20	0	1.00e+00	LOC102551633
Intermittent access day 1 total infusions	27.34	4	1	20	-0.52	4.79e-01	Klhdc8b LOC102551633 Serbp1 Zfand2b
Intermittent access day 15 total infusions	16.75	4	1	20	0.87	1.31e-01	Klhdc8b LOC102551633 Serbp1 Zfand2b
Intermittent access terminal intake (last 3 days)	36.16	4	3	60	0.59	4.09e-01	Klhdc8b LOC102551633 Serbp1 Zfand2b
Intermittent access total infusions	12.75	3	0	0	0	1.00e+00	Klhdc8b LOC102551633 Serbp1
Intermittent access day 1 locomotion	18.98	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access day 15 total locomotion	62.98	2	2	40	0	1.00e+00	LOC102551633 Zfand2b
Intermittent access total locomotion	12.69	2	0	0	0	1.00e+00	LOC102551633 Zfand2b
Intermittent access standard deviation	229.66	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Cocaine induced anxiety	69.5	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Baseline Anxiety	393.92	1	1	20	0	1.00e+00	Zfand2b
Lifetime Intake	11.9	3	0	0	0	1.00e+00	Klhdc8b LOC102551633 Serbp1
Incentive Sensitization - Responses	159.14	2	1	20	0	1.00e+00	LOC102551633 Zfand2b
Incentive Sensitization - Breakpoint	153.67	2	1	20	0	1.00e+00	LOC102551633 Zfand2b
Progressive ratio test 1 active lever presses	22.03	3	1	20	0	1.00e+00	LOC102551633 Serbp1 Zfand2b
Progressive ratio test 1 breakpoint	28.37	3	2	40	0	1.00e+00	LOC102551633 Serbp1 Zfand2b
Progressive ratio test 1 inactive lever presses	19.32	3	1	20	0	1.00e+00	Klhdc8b LOC102551633 Serbp1
Progressive ratio test 2 active lever presses	59.74	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Progressive ratio test 2 breakpoint	58.36	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Progressive ratio test 2 inactive lever presses	25.84	4	1	20	0.85	1.48e-01	Klhdc8b LOC102551633 Serbp1 Zfand2b
Total sessions with >9 infusions	28.08	2	1	20	0	1.00e+00	Klhdc8b Serbp1
Short access day 1 total inactive lever presses	23.34	4	1	20	-0.12	8.80e-01	Klhdc8b LOC102551633 Serbp1 Zfand2b
Short access day 10 total inactive lever presses	49.27	4	3	60	0.99	1.27e-02	Klhdc8b LOC102551633 Serbp1 Zfand2b
Short access day 1 total infusions	45.2	2	1	20	0	1.00e+00	LOC102551633 Serbp1
Short access day 10 total infusions	22.05	2	1	20	0	1.00e+00	Klhdc8b LOC102551633
Short access total infusions	26.87	2	1	20	0	1.00e+00	LOC102551633 Serbp1
Short access day 1 locomotion	42.91	4	1	20	0.9	1.05e-01	Klhdc8b LOC102551633 Serbp1 Zfand2b
Short access day 10 total locomotion	432.47	1	1	20	0	1.00e+00	Zfand2b
Short access total locomotion	209.96	1	1	20	0	1.00e+00	Zfand2b
Compulsive drug intake	40.41	2	1	20	0	1.00e+00	Serbp1 Zfand2b
One hour access (0.3 mA shock)	18.01	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
One hour access (shock baseline)	7.23	2	0	0	0	1.00e+00	Klhdc8b LOC102551633
Number of responses in last shaping day	30.56	3	1	20	0	1.00e+00	LOC102551633 Serbp1 Zfand2b
Locomotion distance, session 1	23.98	1	1	20	0	1.00e+00	Klhdc8b
Locomotion velocity, session 2	10	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 2	33.15	1	1	20	0	1.00e+00	Klhdc8b
Locomotion velocity, session 3	13.21	2	0	0	0	1.00e+00	Klhdc8b Selplg
Locomotion distance, session 3	14.51	1	0	0	0	1.00e+00	Klhdc8b
Stereotopy head waving duration, day 3	7.24	2	0	0	0	1.00e+00	Klhdc8b Selplg
Locomotion velocity, session 7	6.12	1	0	0	0	1.00e+00	Serbp1
Locomotion velocity, session 8	9.36	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 8	52.78	1	1	20	0	1.00e+00	Klhdc8b
Degree of sensitization distance	17.91	2	0	0	0	1.00e+00	Klhdc8b LOC102551633
Condit. Reinf. active minus inactive responses	35.59	1	1	20	0	1.00e+00	Klhdc8b
Condit. Reinf. active-inactive response ratio	25.6	1	1	20	0	1.00e+00	Klhdc8b
Condit. Reinf. active responses	18.23	1	0	0	0	1.00e+00	Klhdc8b
Incentive salience index mean	26.23	1	1	20	0	1.00e+00	Klhdc8b
Condit. Reinf. lever presses	10.81	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 1	63.49	1	1	20	0	1.00e+00	Klhdc8b
Time in novel zone, hab. session 1	13.1	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 1	37.38	1	1	20	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 1	10.76	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 1	10.22	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 2	27.1	1	1	20	0	1.00e+00	Klhdc8b
Time in novel zone, hab. session 2	10.13	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 2	39.96	2	1	20	0	1.00e+00	Klhdc8b Selplg
Total locomotion distance, hab. session 2	19.2	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 2	21.15	1	1	20	0	1.00e+00	Klhdc8b
Novel to familiar place preference ratio	22.33	1	0	0	0	1.00e+00	Klhdc8b
Novelty place preference	20.99	1	0	0	0	1.00e+00	Klhdc8b
Time in novel zone, NPP test	17.06	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, NPP test	106.24	1	1	20	0	1.00e+00	Klhdc8b
Total locomotion distance, NPP test	47.64	1	1	20	0	1.00e+00	Klhdc8b
Locomotion velocity, NPP test	51.12	1	1	20	0	1.00e+00	Klhdc8b
Pavlov. Cond. lever latency	5.45	1	0	0	0	1.00e+00	LOC102551633
Pavlov. Cond. change in total contacts	69.48	1	1	20	0	1.00e+00	Klhdc8b
Pavlov. Cond. index score	14.07	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. latency score	8.82	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. lever contacts	5.74	1	0	0	0	1.00e+00	LOC102551633
Pavlov. Cond. magazine entry number	12.23	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. lever-magazine prob. diff.	14.82	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. response bias	10.49	1	0	0	0	1.00e+00	Klhdc8b
Bone: cortical apparent density	8.87	1	0	0	0	1.00e+00	Selplg
Bone: cortical porosity	6.2	1	0	0	0	1.00e+00	Klhdc8b
Bone: cortical thickness	8.62	1	0	0	0	1.00e+00	Selplg
Bone: cortical tissue density	8.11	1	0	0	0	1.00e+00	Selplg
Bone: endosteal estimation	4	1	0	0	0	1.00e+00	Klhdc8b
Bone: final force	4.4	1	0	0	0	1.00e+00	Klhdc8b
Bone: marrow area	3.15	1	0	0	0	1.00e+00	Klhdc8b
Bone: maximum force	7.19	1	0	0	0	1.00e+00	Klhdc8b
Bone: stiffness	9.06	2	0	0	0	1.00e+00	Klhdc8b LOC102551633
Bone: trabecular number	4.31	1	0	0	0	1.00e+00	Selplg
Distance traveled before self-admin	53.87	1	1	20	0	1.00e+00	LOC102551633
Distance traveled after self-admin	27.77	2	1	20	0	1.00e+00	LOC102551633 Zfand2b
Delta time in closed arm before/after self-admin	11.87	2	0	0	0	1.00e+00	Klhdc8b Serbp1
Delta time in open arm before/after self-admin	25.12	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Diff in mean of infusions in LGA sessions	18.85	1	0	0	0	1.00e+00	Serbp1
Extinction: sum of active levers before priming	26.18	1	0	0	0	1.00e+00	LOC102551633
Active lever presses in extinction session 6	20.91	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Delta ambulatory time before/after self-admin	9.7	2	0	0	0	1.00e+00	LOC102551633 Zfand2b
Time in closed arm before self-admin	28.67	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Time in closed arm after self-admin	7.59	2	0	0	0	1.00e+00	LOC102551633 Serbp1
Time in open arm before self-admin	26.71	2	1	20	0	1.00e+00	LOC102551633 Zfand2b
Sum of active levers in priming session hrs 5-6	11.61	4	0	0	-0.63	3.68e-01	LOC102551633 Selplg Serbp1 Zfand2b
Time to tail flick, vehicle, before self-admin	34.21	2	1	20	0	1.00e+00	LOC102551633 Serbp1
Time to tail flick, test, before self-admin	10.68	1	0	0	0	1.00e+00	Zfand2b
Delta time to tail flick, vehicle, before/after SA	48.33	5	2	40	0.87	5.69e-02	Klhdc8b LOC102551633 Selplg Serbp1 Zfand2b
Ambulatory time before self-admin	18.2	2	0	0	0	1.00e+00	LOC102551633 Zfand2b
Ambulatory time after self-admin	13.56	3	0	0	0	1.00e+00	Klhdc8b LOC102551633 Serbp1
Total heroin consumption	17.64	4	1	20	-0.32	6.82e-01	Klhdc8b LOC102551633 Selplg Serbp1
Area under the delay curve	31.15	1	1	20	0	1.00e+00	Zfand2b
Delay disc. indifference point, 0s delay	28.7	1	1	20	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 16s delay	41.08	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Delay disc. indifference point, 24s delay	27.43	1	0	0	0	1.00e+00	Zfand2b
Delay disc. indifference point, 4s delay	41.82	1	1	20	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 8s delay	74.24	1	1	20	0	1.00e+00	Zfand2b
Delay discount exponential model param	16.14	1	0	0	0	1.00e+00	Zfand2b
Delay discount hyperbolic model param	15.89	1	0	0	0	1.00e+00	Zfand2b
Fecal boli incidents, locomotor time 1	96.73	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Change in fecal boli incidents, locomotor task	13.85	1	0	0	0	1.00e+00	Serbp1
Time >=10cm from walls, locomotor time 1	43.35	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Bouts of movement, locomotor time 1	6.19	1	0	0	0	1.00e+00	Zfand2b
Rest time, locomotor task time 1	16.92	3	0	0	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Distance moved, locomotor task time 1	31.01	1	1	20	0	1.00e+00	Klhdc8b
Vertical activity count, locomotor time 1	52.92	3	2	40	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Bouts of movement, locomotor time 2	21.88	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Total resting periods, locomotor time 2	28.25	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Rest time, locomotor task time 2	35.13	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Distance moved, locomotor task time 2	63.13	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Vertical activity count, locomotor time 2	24.95	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Weight adjusted by age	20.12	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Seeking ratio, delayed vs. immediate footshock	8.02	3	0	0	0	1.00e+00	LOC102551633 Serbp1 Zfand2b
Locomotion in novel chamber post-restriction	16.14	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Progressive ratio	7.25	1	0	0	0	1.00e+00	Klhdc8b
Food seeking constrained by brief footshock	11.87	3	0	0	0	1.00e+00	Klhdc8b Selplg Zfand2b
Run reversals in cocaine runway, females	36.45	1	1	20	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway	34.23	1	1	20	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, F	31.9	1	1	20	0	1.00e+00	Zfand2b
Cd content in liver	20.17	1	0	0	0	1.00e+00	Klhdc8b
Co content in liver	12.69	1	0	0	0	1.00e+00	LOC102551633
Fe content in liver	23.95	2	1	20	0	1.00e+00	Klhdc8b LOC102551633
K content in liver	11.94	2	0	0	0	1.00e+00	Klhdc8b LOC102551633
Mg content in liver	15.79	1	0	0	0	1.00e+00	Klhdc8b
Mn content in liver	5.99	1	0	0	0	1.00e+00	Klhdc8b
Na content in liver	30.48	2	1	20	0	1.00e+00	Klhdc8b LOC102551633
Rb content in liver	34.31	2	1	20	0	1.00e+00	Klhdc8b LOC102551633
Se content in liver	10.41	2	0	0	0	1.00e+00	Klhdc8b LOC102551633
Sr content in liver	22.41	1	0	0	0	1.00e+00	Klhdc8b
Zn content in liver	9.95	1	0	0	0	1.00e+00	Klhdc8b

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	0	0	1.03
Adipose	alternative TSS	0	0	1.05
Adipose	gene expression	0	0	1.07
Adipose	isoform ratio	0	0	1.06
Adipose	intron excision ratio	0	0	1.02
Adipose	mRNA stability	1	0	1.1
BLA	alternative polyA	0	0	1.07
BLA	alternative TSS	0	0	1.12
BLA	gene expression	0	0	1.1
BLA	isoform ratio	0	0	1.07
BLA	intron excision ratio	0	0	1.09
BLA	mRNA stability	0	0	1.09
Brain	alternative polyA	0	0	1.06
Brain	alternative TSS	0	0	1.11
Brain	gene expression	0	0	1.07
Brain	isoform ratio	0	0	1.06
Brain	intron excision ratio	0	0	1.06
Brain	mRNA stability	0	0	1.1
Eye	alternative polyA	0	0	1.04
Eye	alternative TSS	0	0	1.06
Eye	gene expression	0	0	1.13
Eye	isoform ratio	0	0	0.93
Eye	intron excision ratio	0	0	1
Eye	mRNA stability	0	0	1.07
IL	alternative polyA	0	0	1.01
IL	alternative TSS	0	0	0.98
IL	gene expression	0	0	1.03
IL	isoform ratio	0	0	1.02
IL	intron excision ratio	0	0	1.11
IL	mRNA stability	0	0	1.15
LHb	alternative polyA	0	0	1.02
LHb	alternative TSS	0	0	1.09
LHb	gene expression	0	0	1.1
LHb	isoform ratio	0	0	1.01
LHb	intron excision ratio	0	0	1.06
LHb	mRNA stability	0	0	1.07
Liver	alternative polyA	0	0	1.1
Liver	alternative TSS	0	0	1.05
Liver	gene expression	1	0	1.07
Liver	isoform ratio	1	0	1.04
Liver	intron excision ratio	0	0	1.02
Liver	mRNA stability	0	0	1.11
NAcc	alternative polyA	0	0	1.07
NAcc	alternative TSS	0	0	1.14
NAcc	gene expression	0	0	1.09
NAcc	isoform ratio	0	0	1.05
NAcc	intron excision ratio	0	0	1.07
NAcc	mRNA stability	0	0	1.1
OFC	alternative polyA	0	0	1.02
OFC	alternative TSS	0	0	1.1
OFC	gene expression	0	0	1.05
OFC	isoform ratio	0	0	1.07
OFC	intron excision ratio	0	0	1.04
OFC	mRNA stability	0	0	1.08
PL	alternative polyA	0	0	1.06
PL	alternative TSS	0	0	1.12
PL	gene expression	0	0	1.09
PL	isoform ratio	0	0	1.06
PL	intron excision ratio	1	0	1.07
PL	mRNA stability	0	0	1.12
pVTA	alternative polyA	0	0	1.02
pVTA	alternative TSS	0	0	1.08
pVTA	gene expression	0	0	1.1
pVTA	isoform ratio	0	0	1.02
pVTA	intron excision ratio	0	0	1.07
pVTA	mRNA stability	0	0	1.07
RMTg	alternative polyA	1	0.2	1.13
RMTg	alternative TSS	0	0	1.06
RMTg	gene expression	0	0	1.09
RMTg	isoform ratio	0	0	0.99
RMTg	intron excision ratio	0	0	1.1
RMTg	mRNA stability	0	0	1.09